Context: Mounting evidence suggests beneficial effects of brown adipose tissue (BAT) activation on glucose and lipid metabolism in humans. It is unclear whether cold-induced BAT activation affects not only insulin sensitivity but also insulin secretion. Likewise, the role in clearing circulating fatty acids (FAs) has not been fully explored.
addition, BAT activation is associated with altered circulating concentrations of distinct FAs. These data support the concept that human BAT metabolism significantly contributes to whole body glucose and lipid utilization in a coordinated manner. (J Clin Endocrinol Metab 102: [4226] [4227] [4228] [4229] [4230] [4231] [4232] [4233] [4234] 2017) T he metabolic syndrome, comprising obesity, type 2 diabetes or insulin resistance, dyslipidemia, and arterial hypertension, has become a major global health burden (1) . The individual components are known to be tightly interconnected, particularly dyslipidemia and type 2 diabetes or insulin resistance (2) . Two hallmarks of type 2 diabetes mellitus are impaired pancreatic first phase insulin secretion in response to glucose and insulin resistance of metabolically relevant tissues and organs, both contributing to the pathogenesis of hyperglycemia (3) . Insulin resistance is also associated with altered levels of fatty acids (FAs) (4) . In turn, disturbed lipid profile has been called lipotoxicity to describe deleterious effects of elevated FAs on glucose metabolism. However, not all FAs cause lipotoxicity, because some FAs may improve glucose metabolism, whereas others may have negative effects on insulin secretion (5-7).
Mitochondria-rich brown adipose tissue (BAT) links both glucose and lipid metabolism (7, 8) . BAT plays the major role in nonshivering thermogenesis and by virtue of this metabolic function may combust excessive energy by burning FAs and glucose in humans (8, 9) . BAT has gained much attention as a potential target for the development of therapeutic strategies against obesity and related metabolic complications. Recently, experimental protocols have been developed to explore BAT physiology in humans: volunteers are exposed to mild cold aimed at activating BAT while avoiding shivering, because shivering will alter metabolic responses due to increased muscle activity. A growing number of clinical studies have linked BAT activation in humans with changes in energy homeostasis, particularly increased insulin sensitivity (10) (11) (12) , and altered lipid metabolism (13) (14) (15) (16) (17) (18) (19) . However, the effects of cold-induced BAT activation on pancreatic insulin secretion or alterations of plasma FA profiles have not been studied in humans. A recent study in rodents found that cold exposure decreased insulin secretion without affecting glucose tolerance due to improved insulin sensitivity, suggesting a sympathetic nervous system (SNS)-mediated reciprocal adjustment of insulin secretion and insulin sensitivity during cold exposure (20) .
Hypothesizing distinct coordination of glucose and lipid metabolism in response to cold-induced SNS and BAT activation in humans, we studied peripheral insulin sensitivity, pancreatic insulin secretion, and the effects on plasma FA profiles in healthy lean men.
Methods

Participants
Fifteen healthy male volunteers participated in two experimental sessions $4 weeks apart. Their average age and body mass index were 27.1 6 0.8 years and 23.2 6 0.2 kg/m 2 [mean 6 standard error of the mean (SEM)], respectively (Supplemental Table 1 ). Exclusion criteria were chronic or acute illness, current medication of any kind, smoking, alcohol or drug abuse, obesity, and diabetes in first-degree relatives. Furthermore, a subset of three volunteers participated in an additional imaging study to validate cold-induced activation of BAT.
Study protocol
Participants arrived at the research unit after a 12-hour fast ( Fig. 1) at 8:00. Weight was measured on a calibrated column scale (seca, Hamburg, Germany), and electrodes for recording electromyograms to examine potential shivering were fixed to the subject's upper arm, thigh, and belly (Neurofax EEG-9200; Nihon Koden, Tokyo, Japan). Two 18-gauge venous catheters (Vasofix Braunüle; B. Braun, Melsungen, Germany) were inserted into antecubital veins of both arms for subsequent blood sampling and infusions. Subjects put on a water-perfused whole body suit (WPS) (ThermoFlash; Buchenberg, Germany) that was worn throughout the experimental procedure (Supplemental Fig. 1 ). The cooling protocol started with a period of adaptation of 100 minutes (22.00°C) as thermoneutrality vs. mean 18.06 6 0.07°C (mean 6 SEM) as minimal temperature without shivering, and this minimal temperature was maintained during the entire experiment. In case of shivering, as detected by electromyography, temperature of the WPS was increased by steps of 1.00°C until shivering terminated completely. At 11:00 the Botnia clamp was initiated as described before (21) . In brief, the Botnia clamp is a combination of a frequently sampled intravenous glucose tolerance test (IVGTT) followed by a hyperinsulinemic-euglycemic clamp (HEC). Blood was sampled after arrival (basal, 0 minutes), after the adaptation period (after 100 minutes), during the IVGTT (i.e., Figure 1 . Study design. The study was conducted in a cross-balanced repeated within-subject design on two separate days with two experimental conditions. On study day 1, subjects were kept at thermoneutrality (22.00°C) by wearing a WPS. On study day 2, participants were exposed to moderate cold (mean water temperature 18.06°C 6 0.07 SEM, shivering excluded). Thermal adaption, IVGTT, and hyperinsulinemic-euglycemic clamp were performed on both study days. 2, 4, 6, 8, 10, 20, 30, 40, 50 , and 60 minutes after glucose bolus), and at euglycemic steady state of the clamp (i.e., 120, 150 and 180 minutes after start of IVGTT). Insulin sensitivity, expressed as M value, was calculated based on glucose infusion rates during the last 60 minutes of the HEC. Pancreatic first phase insulin secretion, expressed as first phase insulin response (FPIR), was calculated from the sum of serum insulin concentrations at minutes 2, 4, and 6 of the IVGTT. The disposition index (DI) was calculated as FPIR 3 M value. Core body temperature was measured at baseline, after thermal adaptation, and 60, 120, and 180 minutes after the IVGTT with an ear thermometer (Braun ThermoScan type 6014; Braun GmbH, Kronberg, Germany).
PET and PET/computed tomography protocol
To validate cold-induced BAT activation, three volunteers of our study cohort were included in a BAT imaging study in Vienna. [ 18 F]-fluorodeoxyglucose ([ 18 F]-FDG) positron emission tomography (PET) computed tomography (CT) studies were performed during thermoneutrality (23°C ambient temperature) and after moderate cold exposure on 2 study days separated by $14 days. To ensure an optimal course of the protocol, a cooling garment was used to chill participants before PET/CT imaging (CoolShirt Systems, Stockbridge, Georgia; Supplemental Fig. 1 ). Subjects underwent PET/CT measurements in the morning after an overnight fasting period and 60 minutes after [ 18 F]-FDG application (2.5 MBq/kg body weight) on each study day. PET/CT scans were performed with a Siemens Biograph 64 True Point scanner (Siemens Healthcare, Erlangen, Germany). A static PET/CT scanning protocol was used to determine the [
18 F]-FDG uptake; the protocol started with a low-dose CT scan (120 kV, 50 mAs) immediately followed by PET acquisition in three-dimensional mode for 3 minutes. [ 18 F]-FDG uptake was assessed and CT was used for attenuation correction and for anatomical localization of brown fat. PET/CT images were acquired from the base of the skull to midthigh. BAT volume and activity were quantified with a Hermes Hybrid 3D Viewer (Hermes Medical Solutions, London, UK). The regions of interest (ROIs) were generated in the axial fusion image composed by the static [ 18 F]-FDG PET image and the CT image at a Hounsfield unit range between 2180 and 210 according to the Brown Adipose Reporting Criteria in Imaging Studies criteria (22) . ROIs were drawn semiautomatically, with a threshold of standardized uptake value of 2. Only ROIs located in areas with fat density (determined by CT) were considered for brown fat quantification. To determine the effects of cold exposure on skeletal muscle, cubes were selected as volumes of interest in three different muscles. We analyzed the average [ 
Laboratory analyses
Blood glucose concentrations were assessed by the glucose oxidase method (EKF Biosen C-Line glucose analyzer; EKF Diagnostic, Barleben, Germany).
Serum insulin, C-peptide, cortisol, thyroid-stimulating hormone (TSH), and free T4 (fT4) were analyzed with the IMMU-LITE 2000 Immunoassay System (Siemens Healthcare, Erlangen, Germany). Plasma total ghrelin and leptin concentrations were measured via radioimmunoassay (Millipore Corporation, Billerica, MA). Human fibroblast growth factor 21 (FGF21) and adiponectin were determined in serum by enzyme-linked immunosorbent assay (Quantikine; R&D Systems Europe, Abingdon, UK; BioVendor, Heidelberg, Germany). For catecholamine determination, high-performance liquid chromatography followed by chemical detection was performed with the Recipe ClinRep® kit (Recipe Chemicals + Instruments GmbH, Munich, Germany). Blood lipids triacylglycerol (TG), low-density lipoprotein (LDL), high-density lipoprotein (HDL), and total cholesterol were measured with ARCHI-TECT c Systems (Abbott Diagnostics, Wiesbaden, Germany). Twenty-six FAs were analyzed as described previously (24); results of individual plasma FAs are expressed as percentages of total identified FAs after response factor correction. Briefly, this gas chromatography-based method reliably determines relative changes of individual plasma FAs as compared with an internal standard. This method detects all plasma FAs, with FAs transported in triglyceride-rich lipoprotein particles as the majority of plasma FAs.
Statistical analysis
All statistics were performed in RStudio version 3.1.0. P , 0.05, two-sided, was considered significant. The insulin, C-peptide, TSH, fT4, cortisol, total cholesterol, HDL cholesterol, LDL cholesterol, triacylglycerol, leptin, and ghrelin values during euglycemic steady state are averages of three blood samples taken during the last 60 minutes of the HEC. To test for systematic effects of cold-induced BAT activity vs. thermoneutrality, two-way repeated-measurements analyses of variance were calculated with factors condition (two levels, 18.06°C vs. 22.00°C) and time (three levels, basal vs. after thermal adaptation vs. euglycemic steady state; two levels for hormones that were measured at baseline and during euglycemic steady state; and five levels for monitoring core body temperature). For insulin sensitivity, FPIR and post hoc comparison paired t tests were performed; in case of violated normality assumption, paired Wilcoxon signed rank tests were used. Multiple comparisons were taken into account and were adjusted according to Holm-Bonferroni correction, as well as the false discovery rate for FA profiles. Greenhouse-Geisser and Huynh-Field corrected values are reported in case of violated sphericity. Integrals for area under the curve (AUC) were calculated applying the trapezoidal rule from blood samples taken during the IVGTT and the last 60 minutes of the HEC.
Study approvals
In accordance with the Declaration of Helsinki, the study was approved by the local ethics committee of the University of Lübeck (AZ 12/030). PET/CT studies in a subset of the initial cohort were approved by the Ethics Committee of the Medical University of Vienna (EK 1032/2013). Written informed consent was received from all participants before inclusion in both studies.
Results
Cold exposure improves whole body insulin sensitivity but not insulin secretion
Fasting glucose concentrations at the beginning of the experiments, after the adaption phase, and during the euglycemic steady state of the HEC were statistically comparable between conditions (P = 0.595, P = 0.103, and P = 0.410, respectively, Table 1 ). Likewise, corresponding serum insulin levels were similar between conditions (P = 0.354, P = 0.708, and P = 0.717, respectively, Table 1 ). Upon cold-induced BAT activation, peripheral glucose uptake and insulin sensitivity (expressed as M value) increased by 20% during euglycemic steady state (P = 0.04, Fig. 2a) . In contrast, pancreatic first phase insulin secretion in response to the acute glucose load was comparable between conditions (P = 0.62, Fig. 2b ). The DI (insulin secretion adjusted for insulin sensitivity) was nominally increased after cold adaptation as compared with thermoneutrality, but this difference was statistically not significant (thermoneutrality 1025.3 6 273.0 mU/mg/kg vs. cold exposure 1283.9 6 302.8 mU/mg/kg; P = 0.28). In line, total glucose AUC during the IVGTT decreased in response to cold exposure as compared with thermoneutrality, although the change did not reach statistical significance (thermoneutrality 292.5 6 7.5 mmol/L 3 60 minute vs. cold exposure 282.1 6 11.4 mmol/L 3 60 minute; P = 0.24). Sympathetic activation substantially increased upon cold exposure as indicated by significantly higher concentrations of circulating plasma noradrenaline (NA; P , 0.001) and dopamine (DA; P = 0.009), whereas no effects were observed on adrenaline (A) levels (P = 0.73, Table 1 ). Furthermore, in the BAT-activated state, levels of NA and DA increased significantly more from baseline to euglycemic steady state relative to the thermoneutral condition, as illustrated by a significant condition 3 time interaction (NA, P , 0.01 and DA, P = 0.01, Table 1 ). Insulin, C-peptide, TSH, fT4, cortisol, leptin, ghrelin, adiponectin, and FGF21 were not affected by coldinduced BAT activity (P = 0.1, P = 0.54, P = 0.66, P = 0.07, P = 0.74, P = 0.41, P = 0.56, P = 0.19, and P = 0.16, respectively; Table 1 ).
Cold exposure alters plasma lipid profiles
Evaluation of specific plasma FAs revealed a significant increase of lignoceric acid (C24:0) by 21% after cold-induced BAT activation as compared with the thermoneutral control condition (P = 0.04; Table 2 ). Moreover, during euglycemic steady state, levels of eicosanoic acid (C20:1n9), nervonic acid (C24:1n9), and behenic acid (C22:0) were significantly lower during cold-induced BAT activation vs. thermoneutrality (P , 0.001, P = 0.02, and P , 0.001, respectively). Concentrations of total cholesterol, HDL cholesterol, LDL cholesterol, and TG were comparable between conditions (P = 0.61, P = 0.66, P = 0.28, and P = 0.23, respectively; Table 2 ). However, analyses of corresponding AUCs of plasma lipids during euglycemic steady state indicated a significant upregulation of TG on cold-stimulated BAT activation as compared with thermoneutrality (P = 0.03; Table 2 ). For all other lipids, no significant differences in AUC between conditions were observed (cholesterol P = 0.81, HDL P = 0.85, LDL P = 0.89; Table 2 ). Diurnal changes in parameters over time, independently of cold-induced BAT activation, are indicated in Table 1 and in Supplemental Table 3 .
Cold exposure increases BAT metabolism in humans
Exposure to moderate cold was not accompanied by changes in core body temperature in the entire cohort (P = 0.94; Table 1 ).
As proof of concept, three study participants were subjected to [ 18 F]-FDG PET/CT scans at thermoneutrality and after moderate cold exposure, respectively. Cold exposure increased [ 18 F]-FDG uptake in distinct fat depots at the typical anatomical locations including the cervical, supraclavicular, and paravertebral areas, confirming cold-induced BAT activation (Fig. 3) . Cold exposure did not alter [ 18 F]-FDG uptake in skeletal muscle (Fig. 3) .
Discussion
We used cold exposure to increase BAT activity via stimulation of the SNS. The increase of NA in our entire cohort confirms cold-induced SNS stimulation, because cold exposure typically does not affect the adrenal medulla, and A levels remained unchanged (25, 26) . Interestingly, DA levels also increased significantly. Whereas NA is well recognized to be key in the regulation of SNSmediated BAT thermogenesis, data on DA in the context of BAT activation are scarce. At least in rats, cold exposure causes an increase of DA levels in BAT (27) , and evidence for direct dopaminergic effects on mitochondrial mass and thermogenesis in murine brown adipocytes in vitro was recently published by our group (28) . The increase of plasma DA levels upon cold exposure suggests relevant dopaminergic impact on BAT metabolism in humans. The stimulating effect of mild cold exposure on metabolic BAT activity was additionally confirmed in three individuals of our cohort by FDG PET scans. At the same time, cold exposure did not affect [ 18 F]-FDG uptake into skeletal muscles, another metabolically important tissue potentially affecting glucose metabolism. This finding is in line with previous reports (10-12, 14, 29, 30 ). In sum, these observations suggest that BAT is more important than skeletal muscle tissue in cold-induced glucose uptake in fasted, nonshivering humans. Although previous studies have already suggested that cold-induced BAT activation in humans is associated with increased peripheral glucose uptake due to improved insulin sensitivity (10) (11) (12) , pancreatic insulin secretion has not been studied in this context. Notably, a recent report in rodents found decreased insulin secretion in cold-challenged rats, whereas glucose tolerance remained unchanged (20) . The authors speculated about a brainregulated reciprocal adjustment of insulin secretion and insulin sensitivity to maintain euglycemia during 28 hours of exposure to 5°C. In our study acute exposure to moderate cold increased insulin sensitivity by~20% in young healthy men, which is consistent with most (10-12) but not all (29) previous studies. Moreover, the second hallmark of type 2 diabetes, pancreatic first phase insulin secretion, was not altered by acute cold-induced BAT activation in our cohort of healthy men. Coldinduced improvement of insulin sensitivity without compensatory reduction in pancreatic insulin secretion favored lower glucose concentrations before the Botnia clamp, as well as lower AUC of glucose levels and higher DI during the clamp procedure. Although insulindependent effects on glucose metabolism predominate during an HEC, insulin-independent effects might also contribute to mediate additional effects. Against the background of improved insulin sensitivity, unchanged insulin secretion, and a descriptive, although statistically not significant, drop in circulating glucose, it is tempting to speculate on a disruption of glucose sensing or b-cell reactivity during acute exposure to moderate cold. It has to be clarified whether this constellation during acute cooling reflects just a dynamic process of adaptation and whether this process leads to a reduction in secretory b-cell activity during subchronic or more intense cooling as in rodents.
Lipids are known to modulate insulin sensitivity of insulin-responsive tissues and organs (31) , and BAT oxidative metabolism is fueled by both glucose and lipids (13, 17, 29) . FAs can be delivered to BAT either by TGrich lipoproteins or in an albumin-bound form as nonesterified fatty acids. Using AUC analysis, we found a significant increase in TG levels at the end of the Botnia clamp upon cold exposure. This increase might be due to NA-dependent lipolysis in white adipose tissue, a condition causing increased nonesterified fatty acid flux to the liver and hepatic production of TG-rich very-lowdensity lipoprotein particles in fasting individuals. Indeed, a recent study provided direct evidence that FAs derived from lipolysis of intracellular triglycerides are crucial for acute BAT thermogenesis in humans (18) .
Here, we also provide insight into the distinct regulation of fatty acid profiles in response to cold exposure in men. Lignoceric acid (C24:0), a very long chain saturated fatty acid (VLSFA), concentrations increased significantly after 2 hours of cold exposure. The rise in C24: 0 levels suggests a reduced uptake of this specific FA by cold-responsive tissues. Moreover, analyses of the FA profile after 5 hours of cold exposure revealed reduced levels of eicosanoic acid [C20:1n9, a monounsaturated (13) (14) (15) (16) (17) (18) . Therefore, it is plausible that BAT is crucial in mediating the effects of cold-induced SNS activation on plasma FA profiles in our study. In a broader context, specific FA classes are closely linked with glucose metabolism, including saturated fatty acids (SFAs) that are commonly associated with an increased risk of diabetes mellitus. However, recent studies challenge this simplistic view. Epidemiological data revealed a length-dependent association of SFAs with diabetes (32, 33) and mortality (34): Long-chain SFAs (,C20) were associated with an increased diabetes risk and higher mortality rate, whereas VLSFAs, including C22:0 and C24:0, were associated with lower diabetes risk and mortality. The mechanisms and the significance of the exact chain length of VLSFAs have not been elucidated to date. Epidemiological data also indicate that MUFA-rich diets are associated with improved glucose metabolism (35); these observations include long-chain monounsaturated fatty acids (LMUFAs, i.e., MUFAs $C20). Note that interventional studies with diets rich in LMUFAs revealed low plasma levels of these FAs, suggesting rapid clearing of MUFAs from the blood as mechanistic aspect of their beneficial effects on glucose metabolism (36) . Therefore, lower C20:1n9 and C24:1n9 plasma concentrations found in our current study may support the notion of positive MUFA effects on glycemic control. Based on our data, C22:0, C24:0, C20:1n9, and C24:1n9 are attractive candidates for additional research, exploring the link between lipid, glucose, and BAT metabolism.
Our study has some limitations that must be addressed. First, cold-induced BAT activity was confirmed by [ 18 F]-FDG PET/CT in only three volunteers. As discussed earlier, a number of previous studies have shown that BAT metabolism increases upon cold exposure. We therefore believe that cold-induced BAT activation is not restricted to three of our participants. Second, the study protocol included an acute exposure to mild cold. Metabolic adaptions of BAT and the endocrine pancreas in response to longer periods of cold exposure may be even more pronounced. Therefore, chronic adaptions to more prolonged interventions will have to be determined in future studies. Relatedly, comparing coldinduced effects on insulin secretion in our study with rodent data (20) warrants caution: rats were exposed to lower temperatures for a longer period of time, and humans differ from rodents in their adaption to cold. Furthermore, only healthy men were examined. Therefore, effects of coldinduced BAT activity on insulin secretion and plasma FA profiles in patients with the metabolic syndrome must be addressed in future trials. 
Conclusions
We show here that acute cold exposure, SNS activation, and BAT stimulation are associated with improved whole body glucose metabolism independent of pancreatic insulin secretion in healthy lean subjects. In addition, cold exposure results in distinct alterations of FA profiles, particularly LMUFAs and VLSFAs, a previously unknown aspect of cold-induced metabolic adaptions. These data highlight the growing importance of human SNS and BAT in integrating metabolic pathways relevant for glucose and lipid handling and may open avenues for exploiting BAT function as a therapeutic approach against metabolic disease.
